Highline Technical Innovations, Inc. announces

New Post Public Reply Private Reply Replies (0) Message Board
steve10554 wer123 #6109

Highline Technical Innovations, Inc. announces government-funded testing of Alternative Hydrogen Solutions' environmentally friendly Hy-Impact unit

Mar 20, 2014

OTC Disclosure & News Service

Highline Technical Innovations, Inc. announces government-funded testing of Alternative Hydrogen Solutions' environmentally friendly Hy-Impact unit

PR Newswire

SPRINGDALE, Ark. , March 20, 2014 /PRNewswire/ -- Highline Technical Innovations (HLNT) is pleased to announce the commencement of a U.S. Army Program Management-Mobile Electric Power (PM-MEP) funded evaluation of Alternative Hydrogen Solutions' Hy-Impact unit. The Department of Defense (DOD) is interested in the potential of hydrogen to reduce the emissions of diesel exhaust particulates while improving fuel consumption and engine performance. As a result the DOD has agreed to fund a testing program to assess the Hy-Impact unit's effect on mobile diesel generators (Gensets) with particular interest and emphasis on emissions reduction. The Lindon Group believes the Hy-Impact unit has what the DOD needs to reduce its carbon footprint. Previous local tests have shown substantial reductions in harmful emissions and a successful PM-MEP funded evaluation could give the Hy-Impact unit an important 3rd party verification quantifying its ability to reduce harmful exhaust emissions and improve fuel economy in combustion engines. The testing should be completed by the end of spring 2014. AHS and the Lindon Group recently reported in a combined statement on February 21, 2014 , "We feel the results of this testing will give our companies the ability to generate interest in our Hy-Impact technology across many industries." To date the Lindon Group Inc. has represented AHS on this endeavor and will continue to be the principle point of contact for the DOD.

Safe Harbor Statement
This press release contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the PSLRA of 1995. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. AHS does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

About Highline Technical Innovations, Inc.
Highline Technical Innovations, Inc. (OTCBB: HLNT) is dedicated to producing innovative, high quality products that are economical and environmentally friendly. In 2012, HTI formed a joint venture with Miami -based Alternative Hydrogen Systems Group Sales and Marketing LLC (AHSG) to form Alternative Hydrogen Solutions, LLC (AHS), a company focused on introducing the latest in cost-saving and environmentally responsible technology to industries that rely heavily on the consumption of fossil fuels. Highline Technical Innovations (HTI) is the publicly held partner in this joint venture (AHS) and brings the revolutionary Hy-Impact TM line of fuel saving and emission reducing devices to market. HTI is based in Springdale, AR.
For more information on Highline Technical Innovations, visit:  www.hyimpact.com

About AHS
Alternative Hydrogen Solutions, LLC, a joint venture formed between Highline Technical Innovations, Inc. (OTCBB: HLNT) and Alternative Hydrogen Systems Group Sales and Marketing (AHSG), was formed in 2012, when Arkansas -based Highline Technical Innovations, Inc. (OTCBB: HLNT), creator of the Hy-Impact line of intelligent hydrogen systems, joined forces with Alternative Hydrogen Systems Group Sales and Marketing LLC, in order to bring this revolutionary product to market.
For more information on AHS, visit: www.hyimpact.com

About Lindon Group
Lindon Group Inc. specializes in the distribution and logistics of providing select and unique products to the Construction Industry, US Government and Military. Lindon Group is a product development, innovation and supply firm based in East Providence, RI. Founded in 1999, Lindon Group delivers a full spectrum of services including design, manufacturing, marketing and supply to multiple industries worldwide and is proud to work with and support every branch of the US Military, the Department of Homeland Security, the Department of Justice, the Department of State, the Department of the Interior, Law Enforcement, Military contractors and others. It is comprised of three primary divisions: Lindon Supply, Lindon Design, and Lindon Defense.
For more information on Lindon Group, visit: www.lindongroup.com

Contact: Chad Coats c.coats@hyimpact.com

SOURCE Highline Technical Innovations, Inc.

Copyright © 2014 PR Newswire. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases

SPO Networks, Inc. (SPOI) Stock Research Links

SPOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Promising Interim Findings from Medicus Pharma's BCC Study

Updated Category News Views 164

Positive Interim Analysis from Medicus Pharma Ltd Medicus Pharma Ltd. (NASDAQ: MDCX) has recently shared exciting interim results from its SKNJCT-003 Phase 2 clinical study, which focuses on a non-invasive approach to treat basal cell carcinoma (BCC) of the skin. This news marks a significant milestone as the company aims to revolutionize the treatment options available...

Continue Reading
DroneShield's Immediate Response Kit Wins Platinum Award for Innovation

Updated Category News Views 161

DroneShield's Immediate Response Kit Gains Recognition for Innovation DroneShield has recently been awarded the prestigious Platinum Award for Innovation by Military and Aerospace Electronics, showcasing its Immediate Response Kit (IRK) as a cornerstone in drone detection and defeat technology. This award is a testament to the exceptional capabilities of the IRK, which...

Continue Reading
Jefferies Holds ABB Rating; Analysts Assess Mixed Results

Updated Category News Views 65

Jefferies Maintains Hold Rating on ABB Stock Jefferies recently continued its Hold rating for ABB Ltd (NYSE: ABB) and set a price target of CHF50.00, following the company's third-quarter performance report. The report showcased a mixed array of results, with certain metrics outperforming expectations while others showed disappointing trends. During the third quarter, ABB...

Continue Reading
Surgical Clips Market Projected to Reach $1.8 Billion Soon

Updated Category News Views 211

Overview of the Surgical Clips Market Recent analysis of the surgical clips market reveals an impressive valuation of USD 655.9 million in 2023, with projections indicating a potential growth to USD 1.8 billion by 2032. This remarkable increase is attributed to a compound annual growth rate (CAGR) of 11.9% from 2024. Understanding Surgical Clips and Their Importance...

Continue Reading
Public Disclosure of Opening Position by Keywords Studios Plc

Updated Category News Views 74

Public Opening Position Disclosure for Keywords Studios Plc This document provides important information about a public opening position disclosure related to Keywords Studios Plc. It includes details about individuals or entities holding 1% or more of relevant securities. This disclosure is made in accordance with Rule 8.3 of the Takeover Code, which ensures that all...

Continue Reading